In this observational study, 13 patients with severe COVID-19 and 10 healthy controls were enrolled. The data concerning the analysis of circulating T cells show that, in severe COVID-19 patients, the expansion of these cell compartments is prone to induce antibody response, inflammation (CCR4+ and CCR6+ TFH) and regulation (CD8+ Treg). This pathogenic mechanism could lead us to envision a possible new form of biological target therapy.

Characterization of T lymphocytes in severe COVID-19 patients

Fenoglio D.;Dentone C.;Parodi A.;Di Biagio A.;Bozzano F.;Vena A.;Fabbi M.;Ferrera F.;Altosole T.;Bruzzone B.;Giacomini M.;Pelosi P.;De Maria A.;Bassetti M.;De Palma R.;Filaci G.
2021-01-01

Abstract

In this observational study, 13 patients with severe COVID-19 and 10 healthy controls were enrolled. The data concerning the analysis of circulating T cells show that, in severe COVID-19 patients, the expansion of these cell compartments is prone to induce antibody response, inflammation (CCR4+ and CCR6+ TFH) and regulation (CD8+ Treg). This pathogenic mechanism could lead us to envision a possible new form of biological target therapy.
File in questo prodotto:
File Dimensione Formato  
jmv.27037.pdf

accesso aperto

Descrizione: Articolo su rivista
Tipologia: Documento in versione editoriale
Dimensione 1.65 MB
Formato Adobe PDF
1.65 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/1055604
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact